Mostrando 141 - 160 Resultados de 1,811 Para Buscar '"propranolol"', tiempo de consulta: 0.35s Limitar resultados
  1. 141
    por Kum, Jina J.Y., Khan, Zia A.
    Publicado 2013
    “…The first-line therapy for IH is propranolol, a non-selective β-adrenergic receptor antagonist. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Propranolol inhibits growth of hemangioma-initiating cells but does not induce apoptosis
  2. 142
    “…In a high-throughput screen of FDA-approved drugs we identified anti-NB activity for the nonselective β-adrenergic receptor antagonist propranolol hydrochloride. Propranolol inhibited growth of a panel of fifteen NB cell lines irrespective of MYCN status, and treatment induced apoptosis and decreased proliferation. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Anti-tumor activity of the beta-adrenergic receptor antagonist propranolol in neuroblastoma
  3. 143
    “…But limited and variable data has been reported regarding the role of propranolol in treatment of KMP. We herein reported the successful treatment of mild pediatric KMP with propranolol monotherapy in a case of a five-week-old child with kaposiform hemangioendothelioma with successful treatment of both clinical and hematologic responses. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Successful Treatment of Mild Pediatric Kasabach-Merritt Phenomenon with Propranolol Monotherapy
  4. 144
    “…INTRODUCTION: Propranolol, a nonselective β-blocker, exerts an indirect effect on the vasculature by leaving α-adrenergic receptors unopposed, resulting in peripheral vasoconstriction. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Propranolol attenuates hemorrhage and accelerates wound healing in severely burned adults
  5. 145
    “…A propranolol cohort (propranolol usage >6 months) and nonpropranolol cohort were matched using a propensity score. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Propranolol Reduces Cancer Risk: A Population-Based Cohort Study
  6. 146
    “…Propranolol (PRO) is a well-known and widely used non-selective beta-adrenergic receptor antagonist (beta-blocker), with a range of actions which are of interest in an oncological context. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
  7. 147
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visceral metastatic angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol
  8. 148
    “…We recorded the sedation level and daily dose of sedatives, analgesics, and antipsychotics administered each day for 6 days after starting propranolol, and compared them to the day before starting propranolol. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Sedative Effect of Propranolol on Critically Ill Patients: A Case Series
  9. 149
    “…CONCLUSION: Orally administered propranolol as monotherapy or in combination with other therapeutic modalities may play a key role in the treatment of Kasabach–Merritt syndrome.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Propranolol in the preoperative treatment of Kasabach–Merritt syndrome: a case report
  10. 150
    por Afify, Elham A., Andijani, Najlaa M.
    Publicado 2017
    “…This study investigated the ability of propranolol to potentiate the antinociceptive action of morphine and the possible mechanisms underlying this effect. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Potentiation of Morphine-Induced Antinociception by Propranolol: The Involvement of Dopamine and GABA Systems
  11. 151
    “…This study evaluated the efficacy of oral propranolol comparing to oral steroids in management of pediatric hemangiomas. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Effect of Oral Propranolol versus Oral Corticosteroids in Management of Pediatric Hemangiomas
  12. 152
    por Lou, Huanmin, Xu, Guangqi, Huo, Ran
    Publicado 2018
    “…The object of this study was to analyze the curative effect and safety of propranolol combined with prednisone in the treatment of infantile hemangiomas (IHs). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Curative effect and safety of propranolol combined with prednisone in the treatment of infantile hemangiomas
  13. 153
    “…Propranolol hydrochloride NLC was prepared using cold homogenization. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Ocular Delivery System for Propranolol Hydrochloride Based on Nanostructured Lipid Carrier
  14. 154
    “…This study aimed to characterize the population pharmacokinetics and exposure‐response relationship of propranolol (Hemangiol(®) Syrup for Pediatric) in infants with infantile hemangioma. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Population Pharmacokinetics and Pharmacodynamics of Oral Propranolol in Pediatric Patients With Infantile Hemangioma
  15. 155
    “…Objective: Infantile hemangiomas (IHs) are the most common vascular tumors of infancy. Oral propranolol has achieved great success in treating IHs since 2008. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas
  16. 156
    “…Eventually, hepatic lesions totally disappeared 4.5 months later. Propranolol in dosage of 2.5 mg/kg per day was continued until 6 months after the initial prescription. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy of infantile hepatic hemangioma with propranolol treatment: A case report
  17. 157
    “…PURPOSE: A pilot randomized control trial to compare the efficacy and side effects of intralesional and oral propranolol in periorbital and eyelid capillary hemangiomas. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    To compare intralesional and oral propranolol for treating periorbital and eyelid capillary hemangiomas
  18. 158
    “…The aims of this study were to prepare and characterize hydroxypropyl methylcellulose (HPMC)/polycarbophil (PC) mucoadhesive blend films saturated with propranolol hydrochloride (PNL)-loaded nanoparticles to improve permeability of drugs that undergo first-pass metabolism. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Buccal administration of mucoadhesive blend films saturated with propranolol loaded nanoparticles
  19. 159
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Peduncular hallucinosis related to propranolol self-poisoning: efficacy of intravenous glucagon
  20. 160
    “…Purpose: To evaluate the pharmacological effects of propranolol treatment of patients with central serous chorioretinopathy (CSCR) over 4 months. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Oral Treatment of Central Serous Chorioretinopathy Patients Using Propranolol Tablets
Herramientas de búsqueda: RSS